Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease

This publication has 39 references indexed in Scilit:

• Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
  Clinical Therapeutics, 2007
• Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α
  Circulation Research, 2007
• Combination Therapy with Statins and Omega-3 Fatty Acids
  The American Journal of Cardiology, 2006
• Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II
  American Heart Journal, 2006
• Non–High-Density Lipoprotein Cholesterol: The Forgotten Therapeutic Target
  The American Journal of Cardiology, 2005
• Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
  The American Journal of Cardiology, 2005
• Plasma Lipid Profile and Incident Ischemic Stroke
  Stroke, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study
  Atherosclerosis, 2001
• Change in LDL particle size is associated with change in plasma triglyceride concentration.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992